Latest Alliance News
Sep 11, 2023
Monday, September 11th, 2023 A Pennsylvania oncology group is suing Jefferson Health and Thomas Jefferson University Hospitals, both based in Philadelphia, for allegedly attempting to monopolize cancer care in the area, the Philadelphia Business Journal reported Sept. 7. The lawsuit was filed Sept. 5 by Sellersville-based Alliance Cancer Specialists, a medical practice with 36 oncologists. Alliance accused Jefferson of unreasonable restraint of trade, unfair trade practices, antitrust violations, tortious interference with business relations and breach of contract. The lawsuit seeks monetary damages and an order blocking the system from terminating the hospital privileges of Alliance physicians. The lawsuit said Jefferson is "very close to possessing monopoly power in oncology hospital services in Northeast Philadelphia." It noted the system has taken over multiple local systems and private physicians practices in the area. Jefferson operates 17 hospitals in Southeastern Pennsylvania and Southern New Jersey. It attempted to buy Alliance in 2016, but the group chose to remain an "independent competitor to the ever-growing" Jefferson system, according to the suit. Since then, Jefferson allegedly has campaigned to eliminate Alliance's presence in the oncology market by applying pressure to Jefferson-employed physicians to refer patients only to Jefferson-affiliated physicians and facilities. The suit also claimed Jefferson has "admonished, intimidated and threatened termination or reduction in compensation" to its physicians that sent oncology patients to Alliance. Alliance said it all culminated in the most recent "anti-competitive act" when Jefferson terminated the privileges of Alliance's oncologists at Jefferson Health-Northeast, effective Sept. 16. Jefferson told the Business Journal: "As a matter of Jefferson policy, we do not comment on pending litigation. However, we intend to vigorously defend our position."
Alliance Frequently Asked Questions (FAQ)
Where is Alliance's headquarters?
Alliance's headquarters is located at 18201 Von Karman Avenue, Irvine.
What is Alliance's latest funding round?
Alliance's latest funding round is Other Investors.
Who are the investors of Alliance?
Investors of Alliance include Heritage Group.
Who are Alliance's competitors?
Competitors of Alliance include Epilog.
Compare Alliance to Competitors
BrainSpec is a comprehensive web-based software platform designed to make MRS technology accessible to clinicians and researchers alike. The software combines a linear combinations model based post-processing back-end that represents the most accurate method of measuring brain metabolites with a highly intuitive and user-friendly front-end web-based user interface. This combination allows for high analytical performance while maintaining ease of use and results in reduced case processing time, leading to higher output and lower costs.
Firefly Neuroscience provides clinicians with quantitative and object measurements to aid patients suffering from mental illnesses with brain mapping technology. Its brain network analytics technology provides an objective assessment of cognition. It was formerly known as Elminda. The company was founded in 2006 and is based in Toronto, Canada.
Epilog develops solutions to improve the understanding of brain functions. It offers a solution to neurologists for more accurate and efficient computer-aided diagnosis. The company was founded in 2016 and is based in Ghent, Belgium.
Courtagen Life Sciences (CLS) provides proteomic and genomic products and services to the Life Sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. Avantra Biosciences, a subsidiary of Courtagen Life Sciences, sells instruments, consumables and services to address the need for simple multiplex immunoassays in the research, pre-clinical and clinical diagnostic segments of the Life Sciences industry.